Institution
Beijing Xuanwu Traditional Chinese Medicine Hospital
Recent research
- Health & MedicineOpen access
Abstract Safiglipron is an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist administered without fasting or dietary restrictions. We evaluated its efficacy and safety in OUTSTAND-1, a phase 3, multicenter, randomized, double-blind, placebo-controlled trial at...
- Health & MedicineOpen access
The management of ischial tuberosity pressure ulcers in elderly patients remains a significant challenge in surgical treatment, with high risks of wound dehiscence and recurrence following traditional flap reconstruction. This study aimed to evaluate the efficacy of a novel exter...
- Health & Medicine
A Randomized Placebo-Controlled Trial of HTD1801 Monotherapy in Participants With Type 2 Diabetes
OBJECTIVE: The safety and efficacy of HTD1801 versus placebo were evaluated in participants with type 2 diabetes inadequately controlled with diet and exercise. RESEARCH DESIGN AND METHODS: Key entry criteria of this phase 3, randomized, placebo-controlled trial included type 2 d...
- Engineering & Technology
Diffusion‐Driven Macromolecular Self‐Organization Enables Conformal Perovskite/Silicon Tandems
ABSTRACT Industrial deployment of perovskite/silicon tandem solar cells is limited by the difficulty of forming thick, defect‐controlled wide‐bandgap (WBG) perovskite layers that conformally coat micron‐textured silicon while retaining interfacial passivation. Here, we introduce...
- Health & MedicineOpen access
Case report: a rare case of congenital vulvar malformation that is often overlooked
<title>Abstract</title> <bold>Purpose</bold> This study explores the clinical features, diagnostic criteria, and optimal timing for surgery in primary labia minora fusion, a rare congenital vulvar malformation, emphasizing that appropriate surgical timing can reduce the impact of...